Drug intelligence / Profile preview

Ad-ZBP-89

Development stage
Preclinical
Modality
Gene Therapies
Administration
Intratumoral
01

Overview

Ad-ZBP-89 is a replication-deficient recombinant adenoviral vector designed to express the full-length human ZBP-89 (Zinc-binding protein-89) cDNA. ZBP-89 is a Krüppel-type zinc-finger transcription factor that plays a critical role in regulating cell growth and apoptosis. In preclinical studies, particularly for hepatocellular carcinoma (HCC), Ad-ZBP-89-mediated overexpression of ZBP-89 has been shown to induce apoptosis through both p53-dependent and p53-independent pathways. The mechanism involves the upregulation of pro-apoptotic proteins such as Bak and the downregulation of anti-apoptotic factors, often through epigenetic modulation including the inhibition of histone deacetylase 3 (HDAC3) and DNA methyltransferase 1 (DNMT1). While it serves as a potent research tool for investigating gene therapy approaches in gastrointestinal cancers, it is not currently a marketed pharmaceutical product.

Other names
adenoviral ZBP-89Ad-Flag-ZBP-89Ad-Flag-ZBP89Ad-Flag-ZBP 89

Beyond the preview

Go deeper on Ad-ZBP-89.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ad-ZBP-89.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call